Immune dysfunction and immunotherapy in heart disease

Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years--suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction.